-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on SpyGlass Pharma, Raises Price Target to $44

Benzinga·11/13/2026 13:12:04
Stifel analyst Tom Stephan maintains SpyGlass Pharma (NASDAQ:SGP) with a Buy and raises the price target from $42 to $44.